6–12 Month Peptide Protocol
Synthesis from Bachmeyer, Holyfield & Cross-Referenced Sources
Thread: #bert-biohacking | Date: 2026-04-23 | Exported: 2026-04-24
> ⚠️ All dosages are practitioner/community ranges — not medical advice. Consult a prescribing physician.
Evidence tiers: [RCT] [human-obs] [animal] [in-vitro] [expert-opinion] [anecdotal]
Sources Found
Dr. Trevor Bachmeyer (YouTube / Unbreakable Podcast)
Most directly relevant episodes:
- "If I Could Only Choose 4 Peptides" → MOTS-c, Epitalon, BPC-157, Thymosin Alpha-1
[expert-opinion] - "My Top 5 Peptides" → Retatrutide, Epitalon, BPC-157, MOTS-c, TB-500
[expert-opinion] - "BPC-157 As A Forever Peptide" (Feb 2026) → advocates low-dose daily long-term use
[expert-opinion] - Core philosophy: "a constitution for your body" — foundational biology reset, not short cycles
Josh Holyfield — KLOW Blend Protocol
- Signature healing stack: BPC-157 + TB-500 + KPV + GHK-Cu (the "KLOW" quad)
- Peptide tracker tool: tracker.joshholyfield.com
- Focuses on synergistic healing — all four peptides address different bottlenecks simultaneously
[expert-opinion + anecdotal]
Additional Clinical Sources
BeWell Lifestyle Centers | Perfect B Clinic (Doral FL) | Dr. Iman Bar MD | Peak Health Institute
The Recommended 6–12 Month Stack
Layer 1 — Healing (Daily/Continuous)
The Holyfield KLOW Quad — run continuously or in 6–8 week blocks
BPC-157
- Dose: 250–500 mcg/day SubQ (or oral for gut focus)
- Source: Bachmeyer: "forever peptide" at low daily dose. Holyfield: cornerstone of KLOW blend
- Mechanism: NO pathway, angiogenesis, gut lining, tendon/ligament, mitochondrial function
- Evidence:
[animal]+[anecdotal]+[expert-opinion]
TB-500 (Thymosin Beta-4)
- Dose: 2–5 mg/week SubQ, split Mon/Thu
- Source: Bachmeyer Top 5: cardiac regeneration, systemic healing. Holyfield: KLOW component
- Mechanism: Actin sequestration, systemic circulation, anti-fibrotic, cardiac repair
- Evidence:
[animal]+[anecdotal]
GHK-Cu
- Dose: 1–2 mg/day SubQ (or topical for skin/hair)
- Source: Holyfield KLOW component. Peak Health longevity stack
- Mechanism: Collagen synthesis, anti-inflammatory, oxidative stress reduction, wound healing
- Evidence:
[human-obs (limited)]+[animal]
KPV
- Dose: 500 mcg–1 mg/day SubQ or oral
- Source: Holyfield KLOW component. Gut + systemic inflammation
- Mechanism: Alpha-MSH fragment, NF-κB suppression, gut barrier, antimicrobial
- Evidence:
[animal]+[in-vitro]
> Cycling note: BPC-157 can run continuously per Bachmeyer. TB-500 often cycled 6–8 weeks on, 2–4 weeks off. GHK-Cu and KPV can run continuously.
Layer 2 — Mitochondrial (Weekly or Pulsed)
Validated in PeptideScout KB from the SS-31 + MOTS-c analysis (2026-04-08)
MOTS-c
- Dose: 5 mg 2–3x/week SubQ (or 1 mg/day)
- Source: Bachmeyer #1 pick in "4 peptides" list. Dr. Bar protocol
- Mechanism: AMPK → PGC-1α, mitochondrial biogenesis, exercise mimetic, myostatin inhibition
- Evidence:
[animal]+[human-obs (limited)]+[expert-opinion] - ⚠️ Reconstitute in bacteriostatic water or 0.9% NaCl ONLY — never PBS
SS-31 (Elamipretide)
- Dose: 2–10 mg/day SubQ
- Source: Dr. Bar protocol. KB-validated synergy with MOTS-c
- Mechanism: Cardiolipin stabilization, ROS scavenging, inner mitochondrial membrane repair
- Evidence:
[RCT (Barth syndrome)]+[animal]+[expert-opinion] - ⚠️ Same vehicle rule applies if co-injecting with MOTS-c. Administer within 5–10 min of mixing
> Cycling note: Both can run in 8–12 week blocks. MOTS-c + SS-31 is a validated synergistic pair (complementary mechanisms, no known contraindications per KB).
Layer 3 — GH Axis / GHRH (Cycled)
Strongest evidence tier in this category
Tesamorelin
- Dose: 1 mg/day SubQ, 5 days on / 2 days off
- Cycle: 3 months ON → 2 months OFF (Perfect B clinical protocol)
- Source: FDA-approved for lipodystrophy. Best GHRH for visceral fat + IGF-1 restoration
- Mechanism: GHRH analog → pituitary GH pulse → IGF-1 → lipolysis, muscle preservation, cognitive
- Evidence:
[RCT]+[human-obs]
Ipamorelin
- Dose: 100–300 mcg/day SubQ (ideally pre-sleep)
- Source: Perfect B protocol: Month 1 at lower dose, escalate months 2–3
- Mechanism: Ghrelin mimetic, selective GH pulse, no cortisol/prolactin spike (clean profile)
- Evidence:
[human-obs (limited)]+[expert-opinion] - Stack with Tesamorelin for synergistic GH release (GHRH + GHRP dual mechanism)
Other GHRH Class Options (if Tesamorelin unavailable)
- CJC-1295 (no DAC) — 100–300 mcg/day, similar mechanism, shorter half-life
- Sermorelin — gentler, good for older patients, lower cost
> Cycling note: GH secretagogues should cycle to prevent receptor downregulation. Standard: 12–16 weeks on, 4–8 weeks off. Tesamorelin's 3-on/2-off is the most clinically validated schedule.
Layer 4 — Longevity (Pulsed / Seasonal)
Epithalon (Epitalon)
- Dose: 10 mg/night SubQ for 10 consecutive nights
- Cycle: 2x/year (every ~6 months). Perfect B protocol
- Source: Bachmeyer: core longevity peptide — "for aging/time"
- Mechanism: Telomerase activation, pineal gland normalization, melatonin regulation, DNA repair
- Evidence:
[animal]+[human-obs (limited, Russian clinical data)]
Additional Longevity Peptides to Consider
Thymosin Alpha-1 (Tα1) — Bachmeyer's 4th pick in his foundational protocol
- 1.5 mg 2x/week SubQ, 4–8 week cycles
- Immune activation, anti-cancer, anti-viral
[RCT]+[human-obs]
Thymalin — pairs with Epitalon in Peak Health longevity stack (immune aging)
[animal]+[human-obs (limited)]
Suggested 6-Month Master Schedule
``` MONTHS 1–3 (Active Build Phase) Daily: BPC-157 (250–500 mcg) + KPV (500 mcg–1 mg) + GHK-Cu (1–2 mg) 2x/week: TB-500 (2.5 mg Mon/Thu) + MOTS-c (5 mg) + SS-31 (5–10 mg) Daily: Tesamorelin (1 mg, 5on/2off) + Ipamorelin (200 mcg pre-sleep)
WEEK 1 (Epithalon pulse): Nightly: Epithalon 10 mg × 10 nights → then done until Month 7
MONTHS 4–5 (Rest/Consolidation) Continue: BPC-157 (low dose, 250 mcg/day — Bachmeyer "forever" approach) Continue: GHK-Cu + KPV (maintenance) OFF: Tesamorelin + Ipamorelin (receptor reset) Continue: MOTS-c + SS-31 (can continue or take 4-week break)
MONTH 6 (Restart GH Axis) Restart: Tesamorelin + Ipamorelin (fresh 3-month cycle begins) Continue: Full healing quad Optional: Thymosin Alpha-1 pulse (4–6 weeks)
MONTH 7 (if extending to 12 months) Epithalon pulse #2 (10 mg × 10 nights) ```
Stacking Compatibility Summary
| Stack | Compatibility | Notes | |---|---|---| | BPC-157 + TB-500 | ✅ Synergistic | Local + systemic healing — the "Wolverine Stack" | | BPC-157 + KPV + GHK-Cu | ✅ Synergistic | Holyfield KLOW quad | | MOTS-c + SS-31 | ✅ Synergistic | KB-validated, complementary mitochondrial mechanisms | | Tesamorelin + Ipamorelin | ✅ Synergistic | GHRH + GHRP dual-axis GH release | | Epithalon | ✅ Compatible | Pulsed, non-competing with all above | | Thymosin Alpha-1 | ✅ Additive | Immune layer, non-competing |
Key Safety Flags
> ⚠️ MOTS-c vehicle: NEVER reconstitute in PBS or HEPES — catastrophic precipitation. Use bacteriostatic water or 0.9% NaCl only.
> ⚠️ SS-31 + MOTS-c co-injection: Same vehicle required. Administer within 5–10 min of mixing. No pre-mixed storage.
> ⚠️ GH axis peptides + cancer history: Contraindicated. IGF-1 elevation is a concern.
> ⚠️ Tesamorelin + insulin resistance: Monitor HbA1c and fasting glucose. Can transiently raise blood sugar.
> ⚠️ Dosage conflicts: Sources vary. Ranges above represent practitioner consensus, not clinical trials. Individual response varies significantly.
> ⚠️ Epithalon: Russian clinical data is real but limited by Western standards. Telomerase activation is a double-edged sword theoretically — avoid in anyone with cancer history.
Evidence Tier Summary
| Peptide | Best Evidence | Notes |
|---|---|---|
| Tesamorelin | [RCT] | FDA-approved, strongest GH evidence |
| SS-31 | [RCT] | Barth syndrome trials |
| Thymosin Alpha-1 | [RCT] | Immune activation |
| BPC-157 | [animal] | No human RCTs yet |
| TB-500 | [animal] | No human RCTs yet |
| MOTS-c | [animal] + [human-obs] | Emerging human data |
| GHK-Cu | [human-obs] | Wound healing studies |
| Epithalon | [animal] + [human-obs] | Russian clinical data |
| KPV | [animal] + [in-vitro] | Least human data |
| Ipamorelin | [human-obs] | Practitioner-dominant evidence |
Sources
- Dr. Trevor Bachmeyer — YouTube / Unbreakable Podcast (Nov 2025–Feb 2026)
[expert-opinion] - Josh Holyfield — KLOW protocol
[expert-opinion] - Perfect B Clinic — Tesamorelin dosage protocol (Apr 2026)
[expert-opinion] - Dr. Iman Bar MD — CJC-1295/Ipamorelin/MOTS-c/SS-31 protocol (Sep 2025)
[expert-opinion] - BeWell Lifestyle Centers — Peptide Protocols Guide
[expert-opinion] - Peak Health Institute — Best Peptide Stacks for Longevity (2025)
[expert-opinion] - PeptideScout KB — SS-31 + MOTS-c co-administration analysis (2026-04-08)
[animal + in-vitro]